Wetherby Asset Management Inc. raised its stake in Illumina, Inc. (NASDAQ:ILMN) by 10.7% during the second quarter, Holdings Channel reports. The fund owned 1,733 shares of the life sciences company’s stock after buying an additional 167 shares during the period. Wetherby Asset Management Inc.’s holdings in Illumina were worth $301,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Advocacy Wealth Management Services LLC acquired a new position in Illumina during the first quarter valued at $102,000. Advisory Services Network LLC acquired a new position in Illumina during the first quarter valued at $117,000. Gemmer Asset Management LLC increased its position in Illumina by 5.7% in the first quarter. Gemmer Asset Management LLC now owns 686 shares of the life sciences company’s stock valued at $117,000 after buying an additional 37 shares during the last quarter. Patten Group Inc. increased its position in Illumina by 2.7% in the first quarter. Patten Group Inc. now owns 965 shares of the life sciences company’s stock valued at $166,000 after buying an additional 25 shares during the last quarter. Finally, NN Investment Partners Holdings N.V. increased its position in Illumina by 11.3% in the second quarter. NN Investment Partners Holdings N.V. now owns 985 shares of the life sciences company’s stock valued at $171,000 after buying an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 93.91% of the company’s stock.

Illumina, Inc. (ILMN) opened at 193.92 on Wednesday. The company’s 50-day moving average is $180.27 and its 200 day moving average is $174.41. The company has a market cap of $28.31 billion, a price-to-earnings ratio of 38.91 and a beta of 0.83. Illumina, Inc. has a 52-week low of $119.37 and a 52-week high of $199.95.

Illumina (NASDAQ:ILMN) last issued its earnings results on Tuesday, August 1st. The life sciences company reported $0.82 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.68 by $0.14. Illumina had a return on equity of 19.69% and a net margin of 30.27%. The business had revenue of $662 million during the quarter, compared to analyst estimates of $642.38 million. During the same quarter in the previous year, the firm earned $0.86 EPS. Illumina’s revenue was up 10.3% on a year-over-year basis. Equities analysts forecast that Illumina, Inc. will post $3.65 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This news story was reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of United States and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.watchlistnews.com/wetherby-asset-management-inc-raises-stake-in-illumina-inc-ilmn/1493648.html.

Several research firms have weighed in on ILMN. BidaskClub upgraded shares of Illumina from a “sell” rating to a “hold” rating in a report on Monday, August 7th. Barclays PLC restated an “equal weight” rating and set a $150.00 price objective on shares of Illumina in a report on Wednesday, August 9th. Vetr upgraded shares of Illumina from a “hold” rating to a “buy” rating and set a $209.78 price objective on the stock in a report on Wednesday, August 9th. Zacks Investment Research downgraded shares of Illumina from a “buy” rating to a “hold” rating in a report on Friday, August 4th. Finally, First Analysis upgraded shares of Illumina from an “underweight” rating to an “equal weight” rating and set a $176.00 price objective on the stock in a report on Wednesday, August 2nd. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and eleven have assigned a buy rating to the stock. Illumina presently has an average rating of “Hold” and a consensus target price of $177.01.

In other Illumina news, SVP Charles Dadswell sold 145 shares of the business’s stock in a transaction dated Monday, June 5th. The stock was sold at an average price of $184.75, for a total value of $26,788.75. Following the completion of the transaction, the senior vice president now owns 10,791 shares of the company’s stock, valued at approximately $1,993,637.25. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jay T. Flatley sold 15,000 shares of the business’s stock in a transaction dated Tuesday, July 18th. The stock was sold at an average price of $170.77, for a total value of $2,561,550.00. Following the completion of the transaction, the director now directly owns 534,176 shares of the company’s stock, valued at approximately $91,221,235.52. The disclosure for this sale can be found here. In the last three months, insiders sold 134,010 shares of company stock valued at $23,946,015. 1.60% of the stock is owned by insiders.

Illumina Company Profile

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Want to see what other hedge funds are holding ILMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Illumina, Inc. (NASDAQ:ILMN).

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.